Notable Holders of Salix Pharmaceuticals Ltd (SLXP)

  |   Expand Research on SLXP   |   * Does Not Fully Represent All Holders
Fund Title Shares % Owned Source
F&C Asset Management plc NOTE 03/19 1.5 2,890,000 4.56% 13F
EXPO CAPITAL MANAGEMENT LLC COM 350,000 0.55% 13F
ING INVESTMENT MANAGEMENT CO COM 243,187 0.38% 13F
1798 Global Partners (Cayman Islands) Ltd. COM 175,000 0.28% 13F
BMO FINANCIAL CORP COM 136,377 0.22% 13F
BBT Capital Management, Inc. 111,900 0.18% 13F
NORTHERN TRUST CO OF CONNECTICUT COM 75,953 0.12% 13F
MFC GLOBAL INVESTMENT MANAGEMENT (U.S.), LLC COM 74,288 0.12% 13F
SEI TRUST CO COM 65,576 0.10% 13F
ALLIANZ GLOBAL INVESTORS OF AMERICA L P COM 61,900 0.10% 13F
WEISS GEORGE A COM 60,000 0.09% 13F
UBS AG COM 56,648 0.09% 13F
PUTNAM INVESTMENT MANAGEMENT LLC 56,588 0.09% 13F
Adamant Biomedical Investments AG COM 45,000 0.07% 13F
Loeb Offshore Management LP COM 40,000 0.06% 13F
Condorcet Global Opportunity Fund, LLC COM 35,000 0.06% 13F
Stux Capital Management, LLC COM 27,200 0.04% 13F
Radium Fund Advisors LLC COM 20,309 0.03% 13F
BlueCrest Capital Management LLP (CALL) COM 20,000 0.03% 13F
Missouri Valley Partners, Inc. COM 16,991 0.03% 13F
RODNEY SQUARE MANAGEMENT CORP COMMON 8,992 0.01% 13F